Skip to main content
MicroTech Medical (Hangzhou) Co., Ltd. logo

MicroTech Medical (Hangzhou) Co., Ltd. — Investor Relations & Filings

Ticker · 2235 HKEX Manufacturing
Open in API
Filings indexed 349 across all filing types
Latest filing 2026-04-13 Transaction in Own Shar…
Country HK Hong Kong
Listing HKEX 2235

About MicroTech Medical (Hangzhou) Co., Ltd.

http://www.microtechmd.com

MicroTech Medical, established in 2011, specializes in comprehensive diabetes management solutions. The company researches, develops, and commercializes medical devices for both diabetes monitoring and treatment. Its product portfolio includes Continuous Glucose Monitoring Systems (CGMS), Blood Glucose Monitoring Systems (BGMS), and advanced treatment technologies. A key innovation is the independently developed patch insulin pump system, which incorporates an algorithm module for data analysis. MicroTech is committed to providing user-friendly devices and integrating monitoring and treatment through a developing cloud-based management platform.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Return
Transaction in Own Shares Classification · 1% confidence The document is a regulatory "Next Day Disclosure Return" under Hong Kong Listing Rules detailing changes in issued shares and treasury shares, specifically share repurchase activity, including quantities, prices, and confirmations. It is a report of the company buying back its own shares. This matches the “Transaction in Own Shares” filing category (POS).
2026-04-13 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 1% confidence The document is a ‘Next Day Disclosure Return’ (FF305) filed under Hong Kong Main Board Rule 13.25A/GEM Rule 17.27A, detailing changes in issued shares and treasury shares, specifically reporting an on-market repurchase of 50,000 shares and confirmation of compliance. This is a regulatory report of the company buying back its own shares. It fits the ‘Transaction in Own Shares’ category (code POS).
2026-04-10 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 1% confidence The document is a regulatory disclosure form (FF305 Next Day Disclosure Return) filed with the Hong Kong Stock Exchange under Main Board Rule 13.25A/10.06 and GEM rules, detailing the company’s own share repurchase (35,900 shares) and changes in treasury shares. This is a report of the company buying back its own shares. It precisely matches the definition of “Transaction in Own Shares” (Code: POS) rather than a simple announcement or other report type.
2026-04-09 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 1% confidence The document is a Hong Kong ‘Next Day Disclosure Return’ detailing changes in issued shares, repurchases of treasury shares, on-market repurchase details, and confirmations under the Listing Rules. It is a report of the company’s own share transactions (share buyback and treasury share movements), matching the “Transaction in Own Shares” category. Therefore, it should be classified under POS.
2026-04-08 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2026
Regulatory Filings
2026-04-08 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 1% confidence The document is a Hong Kong Exchange “Next Day Disclosure Return” (FF305) form reporting changes in issued shares and the on‐market repurchase of treasury shares (Section I and II). It details the repurchase of 50,000 ordinary shares as treasury shares and confirms compliance with Main Board Rules. This is not a general announcement or an Annual/Interim Report, but a mandatory regulatory filing disclosing a share buy-back transaction. Therefore, it falls under Transaction in Own Shares (POS).
2026-04-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.